Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Nov 22 2021 | Bristol Myers Squibb Announces New PDUFA Date for Mavacamten Industry News In The News Industry Read More Nov 18 2021 | Medicare Coverage of Innovative Technology (MCIT) HFSA News Advocacy Read More Nov 16 2021 | US FDA accepts supplemental New Drug Application and grants Priority Review for Jardiance® for adults with heart failure independent of left ventricular ejection fraction Industry News Industry Read More Nov 14 2021 | HFSA President's Update: November 2021 HFSA News President's Updates Read More Nov 12 2021 | Sex Matters (in Heart Failure) HFSA News Journal of Cardiac Failure Press Release Research Read More Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Nov 22 2021 | Bristol Myers Squibb Announces New PDUFA Date for Mavacamten Industry News In The News Industry Read More
Nov 16 2021 | US FDA accepts supplemental New Drug Application and grants Priority Review for Jardiance® for adults with heart failure independent of left ventricular ejection fraction Industry News Industry Read More
Nov 12 2021 | Sex Matters (in Heart Failure) HFSA News Journal of Cardiac Failure Press Release Research Read More
